1. Aikat BK, Bhusnurmath SR, Chhuttani PN, et al: The pathology of noncirrhotic portal fibrosis. A review of 32 autopsy cases. Hum Pathol 10: 405-418, 1979.

2. Alvarez F, Bernard O, Brunelle F, et al: Portal obstruction in children. I. Clinical investigation and hemorrhage risk. J Pediatr 103: 696-702, 1983.

3. Arakawa M, Kage M, Fukuda K, et al: Pathology of extrahepatic portal obstruction in Japan. In Okuda K, Omata M (eds): Idiopathic Portal Hypertension. Japan Medical Research Publication no. 21. Tokyo, 1983, University of Toyko Press. pp 117-127.

4. Barnard JA, Marshall GS, Neblett WW, et al: Noncirrhotic portal fibrosis after Wilms' tumor therapy. Gastroenterology 90: 1054-1056, 1986.

5. Boyer JL, Hales MR, Klatskin G: "Idiopathic" portal hypertension due to occlusion of intrahepatic portal veins by organized thrombi. A study based on postmortem vinylite-injection corrosion and dissection of the intrahepatic vasculature in 4 cases. Medicine 53: 77-91, 1974.

6. Boyer JL, Sen Gupta KP, Biswas SK, et al: Idiopathic portal hypertension. Comparison with portal hypertension of cirrhosis and extrahepatic portal vein obstruction. Ann Intern Med 66: 41-68, 1967.

7. Brown KM, Kaplan MM, Donowitz M: Extrahepatic portal venous thrombosis: Frequent recognition of associated diseases. J Clin Gastroenterol 7: 153-159, 1985.

8. Cohen J, Edelman RR, Chopra S: Portal vein thrombosis: A review. Am J Med 92: 173-182, 1992.

9. Dodds WJ, Erickson SJ, Taylor AJ, et al: Caudate lobe of the liver: Anatomy, embryology, and pathology. AJR 154: 87-93, 1990.

10. Eckhauser FE, Appelman HD, Knol JA, et al: Noncirrhotic portal hypertension: Differing patterns of disease in children and adults. Surgery 94: 721-728, 1983.

11. Futagawa S, Fukazawa M, Horisawa M, et al: Portographic liver changes in idiopathic noncirrhotic portal hypertension. AJR 134: 917-923, 1980.

12. Groszmann RJ, Atterbury CE: The pathophysiology of portal hypertension: A basis for classification. Semin Liver Dis 2: 177-186, 1982.

13. Horrocks P, Tapp E: Zahn's 'infarcts' of the liver. J Clin Pathol 19: 475-478, 1966.

14. Kameda H, Yamazaki K, Imai F, et al: Obliterative portal venopathy: A comparative study of 184 cases of extrahepatic portal obstruction and 469 cases of idiopathic portal hypertension. J Gastroenterol Hepatol 1: 139-149, 1986.

15. Kingham JGC, Levison DA, Stansfeld AG, Dawson AM: Non-cirrhotic intrahepatic portal hypertension: A long term follow-up study. Q J Med 50: 259-268, 1981.

16. Knockaert DC, Robaeys GK, Cox EJ, Marchal GJ: Suppurative pylethrombosis: A changing clinical picture. Gastroenterology 97: 1028-1030, 1989.

17. Levison DA, Kingham JGC, Dawson AM, Stansfeld AG: Slow cirrhosis -- or no cirrhosis? A lesion causing benign intrahepatic portal hypertension. J Pathol 137: 253-272, 1982.

18. Ludwig J, Batts KP, Ploch M, et al: Endotheliitis in hepatic allografts. Mayo Clin Proc 64: 545-554, 1989.

19. Maksoud JG, Mies S, da Costa Gayotto LC: Hepatoportal sclerosis in childhood. Am J Surg 151: 484-488, 1986.

20. Mikkelsen WP, Edmondson HA, Peters RL, et al: Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg 162: 602-618, 1965.

21. Nakanuma Y, Ohta G, Doishita K, Maki H: Granulomatous liver disease in the small hepatic and portal veins. Arch Pathol Lab Med 104: 456-458, 1980.

22. Nakanuma Y, Ohta G, Kobayashi K, Kato Y: Histological and histometric examination of the intrahepatic portal vein branches in primary biliary cirrhosis without regenerative nodules. Am J Gastroenterol 77: 405-413, 1982.

23. Nakanuma Y, Ohta G, Kurumaya H, et al: Pathological study on livers with noncirrhotic portal hypertension and portal venous thromboembolic occlusion: Report of seven autopsy cases. Am J Gastroenterol 79: 782-789, 1984.

24. Nataf C, Feldmann G, Lebrec D, et al: Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation. Gut 20: 531-537, 1979.

25. Navarro C, Clain DJ, Kondlapoodi P: Perforated diverticulum of the terminal ileum: A previously unreported cause of suppurative pylephlebitis and multiple hepatic abscesses. Dig Dis Sci 29: 171-177, 1984.

26. Nayak NC: Phlebothrombotic nature of noncirrhotic portal fibrosis. In Okuda K, Omata M (eds): Idiopathic Portal Hypertension. Japan Medical Research Publication no. 21. Tokyo, 1983, University of Toyko Press. pp 291-298.

27. Nayak NC, Nundy S: Pathology of extrahepatic portal obstruction. In Okuda K, Omata M (eds): Idiopathic Portal Hypertension. Japan Medical Research Publication no. 21. Tokyo, 1983, University of Toyko Press. pp 107-114.

28. Nayak NC, Ramalingaswami V: Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly. Arch Pathol 87: 359-369, 1969.

29. Ohnishi K, Okuda K, Ohtsuki T, et al: Formation of hilar collaterals or cavenerous transformation after portal vein obstruction by hepatocellular carcinoma. Observations in ten patients. Gastroenterology 87: 1150-1153, 1984.

30. Ohnishi K, Saito M, Terabayashi H, et al: Development of portal vein thrombosis complicating idiopathic portal hypertension. A case report. Gastroenterology 88: 1034-1040, 1985.

31. Okuda K: Obliterative portal venopathy: do extrahepatic portal obstruction and idiopathic portal hypertension represent the same disease with varying sites of involvment? J Gastroenterol Hepatol 1: 191-199, 1986.

32. Okuda K, Kono K, Ohnishi K, et al: Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis and splenomegaly. Gastroenterology 86: 600-610, 1984.

33. Okuda K, Nakashima T, Okudaira M, et al: Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. Liver 2: 176-192, 1982.

34. Okuda K, Ohnishi K, Kimura K, et al: Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 89: 279-286, 1985.

35. Sahni P, Pande GK, Nundy S: Extrahepatic portal vein obstruction. Br J Surg 77: 1201-1202, 1990.

36. Sarin SK: Non-cirrhotic portal fibrosis. Gut 30: 406-415, 1989.

37. Shepherd P, Harrison DJ: Idiopathic portal hypertension associated with cytotoxic drugs. J Clin Pathol 43: 206-210, 1990.

38. Sherlock S: Extrahepatic portal venous hypertension in adults. Clin Gastroenterol 14: 1-19, 1985.

39. Snover DC, Weisdorf SA, Ramsay NK, et al: Hepatic graft versus host disease: A study of the predictive value of liver biopsy in diagnosis. Hepatology 4: 123-130, 1984.

40. Terada T, Nakanuma Y, Obata H: HLA-DR expression on the microvasculature of portal tracts in idiopathic portal hypertension. Immunohistochemical characteristics and relation to portal phlebosclerosis. Arch Pathol Lab Med 115: 993-997, 1991.

41. Thomas LB, Popper H, Berk PD, et al: Vinyl-chloride-induced liver disease. From idiopathic portal hypertension (Banti's syndrome) to angiosarcoma. N Engl J Med 292: 17-22, 1975.

42. Triger DR: Extrahepatic portal venous obstruction. Gut 28: 1193-1197, 1987.

43. Valla D, Casadevall N, Huisse MG, et al: Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology 94: 1063-1069, 1988.

44. Villeneuve JP, Huet P-M, Joly J-G, et al: Idiopathic portal hypertension. Am J Med 61:459-464, 1097.

45. Wanless IR: Micronodular transformation (nodular regenerative hyperplasia) of the liver: A report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 11: 787-797, 1990.

46. Wanless IR, Bernier V, Seger M: Intrahepatic portal vein sclerosis in patients without a history of liver disease. An autopsy study. Am J Pathol 106: 63-70, 1982.

47. Wanless IR, Peterson P, Das A, et al: Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myleoid metaplasia: A clinicopathologic study of 145 patients examined at autopsy. Hepatology 12: 1166-1174, 1990.

48. Webb LJ, Sherlock S: The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med 68: 627-639, 1979.

49. Witte CL, Brewer ML, Witte MH, Pond GB: Protean manifestations of pylethrombosis. A review of thirty-four patients. Ann Surg 202: 191-202, 1985.

50. Zafrani ES, von Pinaudeau Y, Dhumeaux D: Drug-induced vascular lesions of the liver. Arch Intern Med 143: 495-502, 1983.

51. Arcidi JM Jr, Moore GW, Hutchins GM: Hepatic morphology in cardiac dysfunction. Am J Pathol 104: 159-166, 1981.

52. Birgens HS, Henriksen J, Matzen P, Poulsen H: The shock liver. Clinical and biochemical findings in patients with centrilobular liver necrosis following cardiogenic shock. Acta Med Scand 204: 417-421, 1978.

53. Buck FS, Koss MN: Hepatic amyloidosis: Morphologic differences between systemic AL and AA types. Hum Pathol 22: 904-907, 1991.

54. Bynum TE, Boitnott JK, Maddrey WC: Ischemic hepatitis. Dig Dis Sci 24: 129-135, 1979.

55. Campra JL, Reynolds TB: The hepatic circulation. In Arias IM, Jakoby WB, Popper H, et al (eds): The LIver, Biology and Pathobiology, 2nd ed. New York, 1988, Raven Press.

56. Chen V, Hamilton J, Qizilbash A: Hepatic infarction. A clinicopathologic study of seven cases. Arch Pathol Lab Med 100: 32-36, 1976.

57. Chopra S, Rubinow A, Koff RS, Cohen AS: Hepatic amyloidosis. A histopathologic analysis of primary (AL) and secondary (AA) forms. Am J Pathol 115: 186-193, 1984.

58. Cohen JA, Kaplan MM: Left-sided heart failure presenting as hepatitis. Gastroenterology 74: 583-587, 1978.

59. de la Monte S, Arcidi JM, Moore GW, Hutchins GM: Midzonal necrosis as a pattern of hepatocellular injury after shock. Gastroenterology 86: 627-631, 1984.

60. Gibson PR, Dudley FJ: Ischemic hepatitis: Clinical features, diagnosis and prognosis. Aust NZ J Med 14: 822-825, 1984.

61. Hashimoto E, Ludwig J, MacCarty RL, et al: Hepatoportal arteriovenous fistula: Morphologic features studied after orthotopic liver transplantation. Hum Pathol 20: 707-709, 1989.

62. Ishak KG: New developments in diagnostic liver pathology. In Farber E, Phillips MJ, Kaufman N (eds): Pathogenesis of Liver Diseases. IAP monograph no. 28. Baltimore, 1987, Williams & Wilkins.

63. Jacobs MB: Hepatic infarction related to oral contraceptive use. Arch Intern Med 144: 642-643, 1984.

64. Kanel GC, Ucci AA, Kaplan MM, Wolfe HJ: A distinctive perivenular hepatic lesion associated with heart failure. Am J Clin Pathol 73: 235-239, 1980.

65. Kibbler CC, Cohen DL, Cruicshank JK, et al: Use of CAT scanning in the diagnosis and management of hepatic artery aneurysm. Gut 26: 752-755, 1985.

66. Kisloff B, Schaffer G: Fulminant hepatic failure secondary to congestive heart failure. Am J Dig Dis 21: 895-900, 1976.

67. Ladefoged C, Frifelt JJ: Hepatocellular calcification. Virchows Arch [A] 410: 461-463, 1987.

68. Lefkowitch JH, Mendez L: Morphologic features of hepatic injury in cardiac disease and shock. J Hepatol 2: 313-327, 1986.

69. Liu G, Butany J, Wanless IR, et al: The vascular pathology of human hepatic allografts. Hum Pathol 24: 182-188, 1993.

70. Mace S, Borkat G, Liebman J: Hepatic dysfunction and cardiovascular abnormalities. Occurrence in infants, children, and young adults. AJDC 139: 60-65, 1985.

71. Nouel O, Henrion J, Bernuau J, et al: Fulminant hepatic failure due to transient circulatory failure in patients with chronic heart disease. Dig Dis Sci 25: 49-52, 1980.

72. Oguma S, Belle S, Starzl TE, Demetris AJ: A histometric analysis of chronically rejected human liver allografts: Insights into the mechanisms of bile duct: Direct immunologic and ischemic factors. Hepatology 9: 204-209, 1989.

73. Reynolds WJ, Wanless IR: Nodular regenerative hyperplasia of the liver in a patient with rheumatoid vasculitis: A morphometric study suggesting a role for hepatic arteritis in the pathogenesis. J Rheumatol 11: 838-842, 1984.

74. Ross RM: Hepatic dysfunction secondary to heart failure. Am J Gastroenterol 76: 511-518, 1981.

75. Rousselet M-C, Kettani S, Rohmer V, et al: A case of temporal arteritis with intrahepatic arterial involvement. Pathol Res Pract 185: 329-331, 1989.

76. Rubel LR, Ishak KG: The liver in fatal exertional heatstroke. Liver 3: 249-260, 1983.

77. Seeley TT, Blumenfeld CM, Ikeda R, et al: Hepatic infarction. Hum Pathol 3: 265-276, 1972.

78. Shibuya A, Unuma T, Sugimoto T, et al: Diffuse hepatic calcification as a sequela to shock liver. Gastroenterology 89: 196-201, 1985.

79. Tracy RE, Johnson WD, Lopez CR, et al: Hypertension and arteriolar sclerosis of the kidney, pancreas, adrenal gland and liver. Virchows Arch [A] 391: 91-97, 1981.

80. Zafrani ES, Pinaudeau Y, Le Cudonnec B, et al: Focal hemorrhagic necrosis of the liver. A clinicopathologic entity possibly related to oral contraceptives. Gastroenterology 79: 1295-1299, 1980.

81. Aoyagi T, Mori I, Ueyama Y, et al: Sinusoidal dilatation of the liver as a paraneoplastic manifestation of renal cell carcinoma. Hum Pathol 20: 1193-1197, 1989.

82. Bagheri SA, Boyer JL: Peliosis hepatis associated with androgenic-anabolic steroid therapy. A severe form of hepatic injury. Ann Intern Med 81: 610-618, 1974.

83. Balázs M: Sinusoidal dilatation of the liver in patients on oral contraceptives: Electron microscopical study of 14 cases. Exp Pathol 35: 231-237, 1988.

84. Bauer TW, Moore GW, Hutchins GM: The liver in sickle cell disease. A clinicopathologic study of 70 patients. Am J Med 69: 833-837, 1980.

85. Bruguera M, Aranguibel F, Ros E, Rodés J: Incidence and clinical significance of sinusoidal dilatation in liver biopsies. Gastroenterology 75: 474-478, 1978.

86. Bruguera M, Caballero T, Carreras E, et al: Hepatic sinusoidal dilatation in Hodgkin's disease. Liver 7: 76-80, 1987.

87. Czapar CA, Weldon-Linne CM, Moore DM, Rhone DP: Peliosis hepatis in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 110: 611-613, 1986.

88. Degott C, Rueff B, Kreis H, et al: Peliosis hepatis in recipients of renal transplants. Gut 19: 748-753, 1978.

89. Esaki Y, Hirokawa K, Fukazawa T, Matsuda T: Immunohistochemical study on the liver in autopsy cases with disseminated intravascular coagulation (DIC) with reference to clinicopathological analysis. Virchows Arch [A} 404: 229-241, 1984.

90. Fisher MR, Neiman HL: Periportal sinusoidal dilatation associated with pregnancy. Cardiovasc Interventional Radiol 7: 299-302, 1984.

91. Gerber MA, Thung SN, Bodenheimer HC Jr, et al: Characteristic histologic triad in liver adjacent to metastatic neoplasm. Liver 6: 85-88, 1986.

92. Gerlag PGG, Lobatto S, Driessen WMM, et al: Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment after kidney transplantation. J Hepatol 1: 339-348, 1985.

93. Johnson CS, Omata M, Tong MJ, et al: Liver involvement in sickle cell disease. Medicine 64: 349-356, 1985.

94. Kemper CA, Lombard CM, Deresinski SC, Tompkins LS: Visceral bacillary epithelioid angiomatosis: Possible manifestations of disseminated cat scratch disease in the immunocompromised host: A report of two cases. Am J Med 89: 216-222, 1990.

95. Laffón A, Moreno A, Gutierrez-Bucero A, et al: Hepatic sinusoidal dilatation in rheumatoid arthritis. J Clin Gastroenterol 11: 653-657, 1989.

96. Larrey D, Fréneaux E, Berson A, et al: Peliosis hepatis induced by 6-thioguanine administration. Gut 29: 1265-1269, 1988.

97. Loomus GN, Aneja P, Bota RA: A case of peliosis hepatis in association with tamoxifen therapy. Am J Clin Pathol 80: 881-883, 1983.

98. Mills LR, Mwakyusa D, Milner PF: Histopathologic features of liver biopsy specimens in sickle cell disease. Arch Pathol Lab Med 112: 290-294, 1988.

99. Minuk GY, Kelly JK, Hwang W-S: Vitamin A hepatotoxicity in multiple family members. Hepatology 8: 272-275, 1988.

100. Nadell J, Kosek J: Peliosis hepatis. Twelve cases associated with oral androgen therapy. Arch Pathol Lab Med 101: 405-410, 1977.

101. Nesher G, Dollberg L, Zimran A, et al: Hepatosplenic peliosis after danazol and glucocorticoids for ITP. N Engl J Med 312: 242-243, 1985.

102. Omata M, Johnson CS, Tong M, Tatter D: Pathologic spectrum of liver diseases in sickle cell disease. Dig Dis Sci 31: 247-256, 1986.

103. Paradinas FJ, Bull TB, Westaby D, Murray-Lyon IM: Hyperplasia and prolapse of hepatocytes into hepatic veins during long-term methyltestosterone therapy: Possible relationships of these changes to the development of peliosis hepatis and liver tumors. Histopathology 1: 225-246, 1977.

104. Perkocha LA, Geaghan SM, Yen TSB, et al: Clinical and pathological features of bacillary peliosis hepatis in association with human immunodeficiency virus infection. N Engl J Med 323: 1581-1586, 1990.

105. Popper H, Thomas LB, Telles NC, et al: Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Am J Pathol 92: 349-376, 1978.

106. Scoazec J-Y, Marche C, Girard P-M, et al: Peliosis hepatis and sinusoidal dilatation during infection by the human immunodeficiency virus (HIV). An ultrastructural study. Am J Pathol 131: 38-47, 1988.

107. Shimamura K, Oka K, Nakazawa M, et al: Distribution patterns of microthrombi in disseminated intravascular coagulation. Arch Pathol Lab Med 107: 543-547, 1983.

108. Simon DM, Krause R, Galambos JT: Peliosis hepatis in a patient with marasmus. Gastroenterology 95: 805-809, 1988.

109. Slater LN, Welch DF, Min K-W: Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatis. Arch Intern Med 152: 602-606, 1992.

110. Sterneck M, Wiesner R, Ascher N, et al: Azathioprine hepatotoxicity after liver transplantation. Hepatology 14: 806-810, 1991.

111. Taxy JB: Peliosis: A morphologic curiosity becomes an iatrogenic problem. Hum Pathol 9: 331-340, 1978.

112. Tsukamoto Y, Nakata H, Kimoto T, et al; CT and angiography of peliosis hepatis. AJR 142: 539-540, 1984.

113. van Erpecum KJ, Janssens AR, Kreuning J, et al: Generalized peliosis hepatis and cirrhosis after long-term use of oral contraceptives. Am J Gastroenterol 83: 572-575, 1988.

114. Voinchet O, Degott C, Scoazec J-Y, et al: Peliosis hepatis, nodular regenerative hyperplasia of the liver, and light-chain deposition in a patient with Waldenström's macroglobulinemia. Gastroenterology 95: 482-486, 1988.

115. Warfel K, Ellis G: Peliosis of the spleen. Arch Pathol Lab Med 106: 99-103, 1982.

116. Winkler K, Poulsen H: Liver disease with periportal sinusoidal dilatation. A possible complication to contraceptive steroids. Scand J Gastroenterol 10: 699-704, 1975.

117. Wold LE, Ludwig J: Peliosis hepatis: Two morphologic variants? Hum Pathol 12: 388-389, 1981.

118. Yanoff M, Rawson AJ: Peliosis hepatis: An anatomic study with demonstration of two varieties. Arch Pathol 77: 159-165, 1964.

119. Zafrani ES, Cazier A, Baudelot A-M, Feldmann G: Ultrastructural lesions of the liver in human peliosis. A report of 12 cases. Am J Pathol 114: 349-359, 1984.

120. Asbury RF, Rosenthal SN, Descalzi ME, et al: Hepatic veno-occlusive disease due to DTIC. Cancer 45: 2670-2674, 1980.

121. Attal M, Huguet F, Rubie H, et al: Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: A prospective, randomized trial. Blood 79: 2834-2840, 1992.

122. Bach N, Thung SN, Schaffner F: Comfrey herb tea-induced hepatic veno-occlusive disease. Am J Med 87: 97-99, 1989.

123. Baert AL, Fevery J, Marchal G, et al: Early diagnosis of Budd-Chiari syndrome by computed tomography and ultrasonography: report of five cases. Gastroenterology 84: 587-595, 1983.

124. Bismuth H, Sherlock D: Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome. Ann Surg 214: 581-589, 1991.

125. Boughton BJ: Hepatic and portal vein thrombosis. Closely associated with chronic myeloproliferative disorders. Br Med J 302: 192-193, 1991.

126. Burt AD, MacSween RNM: Hepatic vein lesions in alcoholic liver disease: Retrospective biopsy and necropsy study. J Clin Pathol 39: 63-67, 1986.

127. Caulet S, Fabre M, Schoevaert D, et al: Quantitative study of centrilobular hepatic fibrosis in alcoholic disease before cirrhosis. Virchows Arch [A] 416: 11-17, 1989.

128. D'Cruz CA, Wimmer RS, Harcke HT, et al: Veno-occlusive disease of the liver in children following chemotherapy for acute myelocytic leukemia. Cancer 52: 1803-1807, 1983.

129. Dejgaard A, Krogsgaard K, Jacobsen M: Veno-occlusive disease and peliosis of the liver after thorotrast administration. Virchows Arch [A] 403: 87-94, 1984.

130. Dunn GD, Hayes P, Breen KJ, Schenker S: The liver in congestive heart failure: a review. Am J Med Sci 265: 174-189, 1973.

131. Fajardo LF, Colby TV: Pathogenesis of veno-occlusive liver disease after radiation. Arch Pathol Lab Med 104: 584-588, 1980.

132. Gill RA, Onstad GR, Cardamone JM, et al: Hepatic veno-occlusive disease caused by 6-thioguanine. Ann Intern Med 96: 58-60, 1982.

133. Goodman ZD, Ishak KG: Occlusive venous lesions in alcoholic liver disease. A study of 200 cases. Gastroenterology 83: 786-796, 1982.

134. Gottfried MR, Sudilovsky O: Hepatic veno-occlusive disease after high-dose mitomycin C and autologous bone marrow transplantation therapy. Hum Pathol 13: 646-650, 1982.

135. Gupta S, Barter S, Phillips GWL, et al: Comparison of ultrasonography, computed tomography, and ^99mTc liver scan in diagnosis of Budd-Chiari syndrome. Gut 28: 242-247, 1987.

136. Gupta S, Blumgart LH, Hodgson HJF: Budd-Chiari syndrome: Long-term survival and factors affecting mortality. Q J Med 60: 781-791, 1986.

137. Haboubi NY, Ali HH, Whitwell HL, Ackrill P: Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: Light microscopy and ultrastructural observations. Am J Gastroenterol 83: 256-261, 1988.

138. Henderson JM, Warren WD, Millikan WJ Jr, et al: Surgical options, hematologic evaluation, and pathologic changes in Budd-Chiari syndrome. Am J Surg 159: 41-50, 1990.

139. Hoffman H du P, Stockland B, von der Heyden U: Membranous obstruction of the inferior vena cava with Budd-Chiari syndrome in children: A report of nine cases. J Pediatr Gastroenterol Nutr 6: 878-881, 1987.

140. Kage M, Arakawa M, Kojiro M, Okuda K: Histopathology of membranous obstruction of the inferior vena cava in the Budd-Chiari syndrome. Gastroenterology 102: 2081-2090, 1992.

141. Katzka DA, Saul SH, Jorkasky D, et al: Azathioprine and hepatic venocclusive disease in renal transplant patients. Gastroenterology 90: 446-454, 1986.

142. Kew MC, McKnight A, Hodkinson J, et al: The role of membranous obstruction of the inferior vena cava in the etiology of hepatocellular carcinoma in Southern African blacks. Hepatology 9: 121-125, 1989.

143. Khuroo MS, Datta DV: Budd-Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract. Am J Med 68: 113-121, 1980.

144. Klatt EC, Koss MN, Young TS, et al: Hepatic hyaline globules associated with passive congestion. Arch Pathol Lab Med 112: 510-513, 1988.

145. Kubo SH, Walter BA, John DHA, et al: Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Arch Intern Med 147: 1227-1230, 1987.

146. Labadie H, Stoessel P, Callard P, Beaugrand M: Hepatic venoocclusive disease and perisinusoidal fibrosis secondary to arsenic poisoning. Gastroenterology 99: 1140-1143, 1990.

147. Leopold JG, Parry TE, Storring FK: A change in the sinusoid-trabecular structure of the liver with hepatic venous outflow block. J Pathol 100: 87-98, 1970.

148. Lewis JH, Tice HL, Zimmerman HJ: Budd-Chiari syndrome associated with oral contraceptive steroids. Review of treatment of 47 cases. Dig Dis Sci 28: 673-683, 1983.

149. Ludwig J, Hashimoto E, McGill DB, et al: Classification of hepatic venous outflow obstruction: Ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc 65: 51-55, 1990.

150. Maddrey WC: Hepatic vein thrombosis (Budd-Chiari syndrome). Hepatology 4: 44S-46S, 1984.

151. Marubbio AT, Danielson B: Hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine. Gastroenterology 69: 739-743, 1975.

152. McDermott WV, Stone MD, Bothe A Jr, Trey C: Budd-Chiari syndrome. Historical and clinical review with an analysis of surgical corrective procedures. Am J Surg 147: 463-466, 1984.

153. McDonald GB, Hinds MS, Fisher LD, et al: Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann Intern Med 118: 255-267, 1993.

154. McDonald GB, Sharma P, Matthews DE, et al: Venocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors. Hepatology 4: 116-112, 1984.

155. McIntyre RE, Magidson JG, Austin GE, Gale RP: Fetal veno-occlusive disease of the liver following high-dose 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and autologous bone marrow transplantation. Am J Clin Pathol 75: 614-617, 1981.

156. Millikan WJ Jr, Henderson JM, Sewell CW, et al: Approach to the spectrum of Budd-Chiari syndrome: Which patients require portal decompression? Am J Surg 149: 167-175, 1985.

157. Mitchell MC, Boitnott JK, Kaufman S, et al: Budd-Chiari syndrome: Etiology, diagnosis and management. Medicine 61: 199-218, 1982.

158. Nakano M, Worner TM, Lieber CS: Perivenular fibrosis in alcoholic liver injury: Ultrastructure and histologic progression. Gastroenterology 83: 777-785, 1982.

159. Nakanuma Y, Ohta G, Doishita K, et al: Granulomatous liver disease in the small hepatic and portal veins. Arch Pathol Lab Med 104: 456-458, 1980.

160. Nakanuma Y, Ohta G, Doishita K: Quantitation and serial section observations of focal venocclusive lesions of hepatic veins in liver cirrhosis. Virchows Arch [A] 405: 429-438, 1985.

161. Nakhleh RE, Wesen C, Snover DC, Grage T: Venoocclusive lesions of the central veins and portal vein radicles secondary to intraarterial 5-fluoro-2'-deoxyuridine infusion. Hum Pathol 20: 1218-1220, 1989.

162. Nasrallah SM, Nassar VH, Galambos JT: Importance of terminal hepatic venule thickening. Arch Pathol Lab Med 104: 84-86, 1980.

163. Nataline MR, Goyette RE, Owensby LC, et al: The Budd-Chairi syndrome in sarcoidosis. JAMA 239: 2657-2658, 1978.

164. Parker RGF: Occlusion of the hepatic veins in man. Medicine 38: 369-402, 1959.

165. Powell-Jackson PR, Ede RJ, Williams R: Budd-Chiari syndrome presenting as fulminant hepatic failure. Gut 27: 1101-1105, 1986.

166. Powell-Jackson PR, Melia W, Canalese J, et al: Budd-Chiari syndrome: Clinical patterns and therapy. Q J Med 51: 79-88, 1982.

167. Read AE, Wiesner RH, LaBrecque DR, et al: Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy. Ann Intern Med 104: 651-655, 1986.

168. Rector WG Jr, Xu Y, Goldstein L, et al: Membranous obstruction of the inferior vena cava in the United States. Medicine 64: 134-143, 1985.

169. Reynolds TB: Budd-Chiari syndrome. In Schiff L, Schiff ER (eds): Diseases of the Liver, 6th ed. Philadelphia, 1987, JB Lippincott. pp 1466-1473.

170. Ridker PM, Ohkuma S, McDermott WV, et al: Hepatic venocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. Gastroenterology 88: 1050-1054, 1985.

171. Rollins BJ: Hepatic veno-occlusive disease. Am J Med 81: 297-306, 1986.

172. Rowland R, Pieterse AS, Kimber RJ, Ward G: Radiation veno-occlusive liver disease. Aust NZ J Med 11: 534-538, 1981.

173. Russi EW, Bansky G, Pfaltz M, et al: Budd-Chiari syndrome in sarcoidosis. Am J Gastroenterol 81: 71-75, 1986.

174. Seltman HJ, Dekker A, Van Thiel DH, et al: Budd-Chiari syndrome recurring in a transplanted liver. Gastroenterology 84: 640-643, 1983.

175. Sevenet F, Deramond H, Hadengue A, et al: Membranous obstruction of the inferior vena cava associated with a myeloproliferative disorder: A clue to membrane formation? Gastroenterology 97: 1019-1021, 1989.

176. Sherlock S: Noncirrhotic extrahepatic and intrahepatic portal hypertension. Sem Liv Dis 2: 202-210, 1982.

177. Shulman HM, Gown AM, Nugent DJ: Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules. Am J Pathol 127: 549-558, 1987.

178. Shulman HM, McDonald GB, Matthews D, et al: An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 79: 1178-1191, 1980.

179. Simson IW: Budd-Chiari syndrome and veno-occlusive disease. In: Peters RL, Craig JR (eds): Liver Pathology. Contemporary Issues in Surgical Pathology, vol 8. New York, 1986, Churchill Livingstrone. pp 299-314.

180. Simson IW: Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa. Gastroenterology 82: 171-178, 1982.

181. Snover DC, Weisdorf S, Bloomer J, et al: Nodular regenerative hyperplasia of the liver following bone marrow transplantation. Hepatology 9: 443-448, 1989.

182. Solano FX, Young E, Talamo TS, Dekker A: Constrictive pericarditis mimicking Budd-Chiari syndrome. Am J Med 80: 113-115, 1986.

183. Stillman AE, Huxtable R, Consroe P, et al: Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in Arizona. Gastroenterology 73: 349-352, 1977.

184. Stuart KL, Bras G: Veno-occlusive disease of the liver. Q J Med 26: 291-315, 1957.

185. Valla D, Casadevall N, Lacombe C, et al: Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med 103: 329-334, 1985.

186. Valla D, Dhumeaux D, Babany G, et al: Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. Gastroenterology 93: 569-575, 1987.

187. Valla D, Le MG, Poynard T, et al: Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. Gastroenterology 90: 807-811, 1986.

188. Vallaeys JH, Praet MM, Roels HJ, et al: The Budd-Chiari syndrome caused by a zygomycete. A new pathogenesis of hepatic vein thrombosis. Arch Pathol Lab Med 113: 1171-1174, 1989.

189. Van Steenbergen W, Beyls J, Vermylen J, et al: 'Lupus' anticoagulant and thrombosis of the hepatic veins (Budd-Chiari syndrome). Report of three patients and review of the literature. J Hepatol 3: 87-94, 1986.

190. Weitz H, Gokel JM, Loeschke K, et al: Veno-occlusive disease of the liver in patients receiving immunosuppressive therapy. Virchows Arch [A] 395: 245-256, 1982.

191. Young ID, Clark RN, Manley PN, et al: Response to steroids in Budd-Chiari syndrome caused by idiopathic granulomatous venulitis. Gastroenterology 94: 503-507, 1988.

192. Alexander J, Cuellar RE, Van Thiel DH: Toxemia of pregnancy and the liver. Semin Liv Dis 7: 55-58, 1987.

193. Arias F, Mancilla-Jimenez R: Hepatic fibrinogen deposits in preeclampsia. N Engl J Med 295: 578-582, 1976.

194. Barron WM: The syndrome of preeclampsia. Gastroenterol Clin No Amer 21: 851-872, 1992.

195. Barton JR, Riely CA, Adamec TA, et al: Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 167: 1538-1543, 1992.

196. Cooney T, Sweeney EC, Coll R, Greally M: 'Pseudocirrhosis' in hereditary hemorrhagic telangiectasia. J Clin Pathol 30: 1134-1141, 1977.

197. Martini GA: The liver in hereditary haemorrhagic telangiectasia: an inborn error of vascular structure with multiple manifestations: a reappraisal. Gut 19: 531-537, 1978.

198. Minakami H, Oka N, Sato T, et al: Preeclampsia: A microvesicular fat disease of the liver? Am J Obstet Gynecol 159: 1043-1047, 1988.

199. Peery WH: Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med 82: 989-997, 1987.

200. Redman CWG: Platelets and the beginnings of preeclampsia. N Engl J Med 323: 478-480, 1990.

201. Rolfes DB, Ishak KG: Liver disease in pregnancy. Histopathology 10: 555-570, 1986.

202. Rolfes DB, Ishak KG: Liver disease in toxemia of pregnancy. Am J Gastroenterol 81: 1138-1144, 1986.

203. Sibai BM, Taslimi MM, El-Nazer A, et al: Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 155: 501-509, 1986.

204. Wanless IR, Gryfe A: Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med 110: 331-335, 1986.

205. Weinstein L: Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 142: 159-167, 1982.